Literature DB >> 26270280

"What Is Our Story?" Philip Morris's Changing Corporate Narrative.

Patricia A McDaniel1, Ruth E Malone1.   

Abstract

OBJECTIVES: We sought to learn how employees reacted to changes in the corporate narrative of Philip Morris Companies (PMC) in the late 1990s and early 2000s.
METHODS: We analyzed archival internal tobacco industry documents about PMC's creation of a new corporate story.
RESULTS: In response to litigation and public opprobrium, PMC replaced its market success-oriented corporate narrative with a new one centered on responsibility. Although management sought to downplay inconsistencies between the old and new narratives, some employees reportedly had difficulty reconciling them, concerned that the responsibility focus might affect company profitability. However, others embraced the new narrative, suggesting radical ideas to prevent youth smoking. These ideas were not adopted.
CONCLUSIONS: PMC's new narrative was unconvincing to many of its employees, who perceived it either as a threat to the company's continued profits or as incongruous with what they had previously been told. As it had done with the public, PMC misled its employees in explaining a narrative repositioning that would help the company continue business as usual. Moving toward a tobacco endgame will require ongoing discursive and symbolic efforts to disrupt this narrative.

Entities:  

Mesh:

Year:  2015        PMID: 26270280      PMCID: PMC4566529          DOI: 10.2105/AJPH.2015.302767

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  24 in total

1.  Tobacco industry documents: treasure trove or quagmire?

Authors:  R E Malone; E D Balbach
Journal:  Tob Control       Date:  2000-09       Impact factor: 7.552

Review 2.  Implications of the tobacco industry documents for public health and policy.

Authors:  Lisa Bero
Journal:  Annu Rev Public Health       Date:  2001-11-06       Impact factor: 21.981

3.  Imagining things otherwise: new endgame ideas for tobacco control.

Authors:  Ruth E Malone
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

Review 4.  Philip Morris's Project Sunrise: weakening tobacco control by working with it.

Authors:  P A McDaniel; E A Smith; R E Malone
Journal:  Tob Control       Date:  2006-06       Impact factor: 7.552

5.  Tobacco industry youth smoking prevention programs: protecting the industry and hurting tobacco control.

Authors:  Anne Landman; Pamela M Ling; Stanton A Glantz
Journal:  Am J Public Health       Date:  2002-06       Impact factor: 9.308

6.  Use of corporate sponsorship as a tobacco marketing tool: a review of tobacco industry sponsorship in the USA, 1995-99.

Authors:  N J Rosenberg; M Siegel
Journal:  Tob Control       Date:  2001-09       Impact factor: 7.552

7.  "Our reach is wide by any corporate standard": how the tobacco industry helped defeat the Clinton health plan and why it matters now.

Authors:  Laura E Tesler; Ruth E Malone
Journal:  Am J Public Health       Date:  2010-05-13       Impact factor: 9.308

8.  The quarter that changed the world.

Authors:  April Roeseler; David Burns
Journal:  Tob Control       Date:  2010-04       Impact factor: 7.552

9.  Creating the "desired mindset": Philip Morris's efforts to improve its corporate image among women.

Authors:  Patricia A McDaniel; Ruth E Malone
Journal:  Women Health       Date:  2009 Jul-Aug

10.  The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR.

Authors:  Gary Fooks; Anna Gilmore; Jeff Collin; Chris Holden; Kelley Lee
Journal:  J Bus Ethics       Date:  2013-01
View more
  1 in total

1.  The World Health Organization's World No Tobacco Day 2020 Campaign Exposes Tobacco and Related Industry Tactics to Manipulate Children and Young People and Hook a New Generation of Users.

Authors:  Simone St Claire; Ranti Fayokun; Alison Commar; Kerstin Schotte; Vinayak M Prasad
Journal:  J Adolesc Health       Date:  2020-07-15       Impact factor: 5.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.